Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection
Clinical trial NCT02363322 · COMPLETED
Trial details
- NCT number
- NCT02363322
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-13
- Primary completion
- 2017-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.